Search

Your search keyword '"Ann Vleugels R"' showing total 2 results
Start Over Author "Ann Vleugels R"
2 results on '"Ann Vleugels R"'

1. De novo autoimmune connective tissue disease and mortality in patients treated with anti-programmed death receptor-1 and anti-programmed death-ligand 1 therapy: a population-level cohort study.

Author

Tang K, Rajeh A, Shaw KS, Nguyen N, Wan G, Hashemi KB, Castillo RL, Kwatra SG, LeBoeuf NR, Ann Vleugels R, and Semenov YR

Subjects
Humans, Female, Male, Middle Aged, Aged, Autoimmune Diseases drug therapy, Autoimmune Diseases mortality, Adult, Cohort Studies, Programmed Cell Death 1 Receptor antagonists & inhibitors, Connective Tissue Diseases drug therapy, Connective Tissue Diseases mortality, Connective Tissue Diseases immunology, B7-H1 Antigen antagonists & inhibitors, Immune Checkpoint Inhibitors therapeutic use, Immune Checkpoint Inhibitors adverse effects
Abstract

Competing Interests: Conflicts of interest Y.R.S. is an advisory board member/­consultant of and has received honoraria from Incyte Corporation, Castle Biosciences, Galderma, Sanofi and Pfizer outside of the submitted work.

Published
2024
Full Text
View/download PDF

2. Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease.

Author

Femia AN and Ann Vleugels R

Subjects
Female, Humans, Male, Acne Vulgaris drug therapy, Acne Vulgaris epidemiology, Inflammatory Bowel Diseases epidemiology, Isotretinoin adverse effects
Abstract

Isotretinoin is a widely prescribed medication for nodulocystic acne. Existing literature is conflicting regarding an association between isotretinoin and inflammatory bowel disease. In this issue, Alhusayen et al. report findings from a 12-year observational study exploring a possible association, and they conclude that acne itself may be responsible for an apparent correlation.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results